Literature DB >> 15121306

Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.

Xuan-Yi Wang1, Zhiyi Xu, Xing Yao, Meiying Tian, Liangdi Zhou, Lifang He, Yumei Wen.   

Abstract

The immunogenicity of a live attenuated HAV vaccine and an inactivated HAV vaccine was compared. Altogether 117 children were vaccinated with either the inactivated or the live attenuated vaccine. Children were bled at months 1, 6, 7, 12 and 24, and the anti-HAV total IgG antibody and IgG subclass profile were assessed. In both vaccinated groups, the geometric mean titer (GMT) of anti-HAV peaked 7 months after the initial dose and declined during the following months. The IgG subclass profiles in both vaccinated groups were highly restricted to IgG1 and IgG3. Both vaccines have been shown highly effective in preventing viral hepatitis A in former studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121306     DOI: 10.1016/j.vaccine.2003.11.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 2.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 3.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 4.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

5.  Do medical college students living in hostel in India need hepatitis A vaccine?

Authors:  Rahul Karna; Rajesh Ruttala; Premashis Kar
Journal:  Indian J Med Res       Date:  2018-08       Impact factor: 2.375

6.  Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children.

Authors:  Monjori Mitra; Nitin Shah; Mma Faridi; Apurba Ghosh; V S Sankaranarayanan; Anju Aggarwal; Suparna Chatterjee; Nisha Bhattacharyya; Ganesh Kadhe; Gaurav Vishnoi; Amey Mane
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 7.  Development, production, and postmarketing surveillance of hepatitis A vaccines in China.

Authors:  Fuqiang Cui; Xiaofeng Liang; Fuzhen Wang; Hui Zheng; Yvan J Hutin; Weizhong Yang
Journal:  J Epidemiol       Date:  2014-03-29       Impact factor: 3.211

Review 8.  A review of immunogenicity and tolerability of live attenuated Hepatitis A vaccine in children.

Authors:  Sameer Rao; J S Mao; Salman Motlekar; Zhuang Fangcheng; Ganesh Kadhe
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452

9.  A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.

Authors:  Kui Xiang; Yuri Kusov; Guan Ying; Wang Yan; Yi Shan; Wu Jinyuan; Yin Na; Zhou Yan; Li Hongjun; Sun Maosheng
Journal:  Viruses       Date:  2017-09-15       Impact factor: 5.048

Review 10.  Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent.

Authors:  Ashish Agrawal; Sanjeev Singh; Shafi Kolhapure; Bernard Hoet; Vidya Arankalle; Monjori Mitra
Journal:  Infect Dis Ther       Date:  2019-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.